Up-regulation of growth hormone receptor immunoreactivity in human melanoma

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1919-1931

  Lincoln, David T ^e   Sinowatz, Fred ^a   Kölle, Sabine ^a   Takahashi, Hiro ^b   Parsons, Peter ^c   Waters, Michael ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Growth hormone; Growth hormone receptor; Immunohistochemistry; Melanoma

Indexed keywords

FORMALDEHYDE; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; MONOCLONAL ANTIBODY; PARAFFIN; SOMATOMEDIN C;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL METABOLISM; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CELL MEMBRANE; CELL NUCLEUS; CYTOSOL; EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; GOLGI APPARATUS; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MELANOCYTES; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEVUS, PIGMENTED; RECEPTORS, SOMATOTROPIN; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032801586     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Marquardt H, Todaro GJ: Human transforming growth factor: Production by a melanoma cell line, purification, and initial characterization. J Biol Chem 257: 5220-5225, 1982.
2. Ellem KAO, Kay GF: The nature of conditioning nutrients for human malignant melanoma cultures. J Cell Sci 62: 249-266, 1983.
3. Westermark B, Johnsson A, Paulsson Y, Betsholtz C, Heldin C, Herlyn M, Rodeck U, Koprowski H: Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factors (PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 83: 7197-7200, 1986.
4. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton F, Spiess J, Bordoni R, Francke U, Derynck R: Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to b-thromboglobulin. EMBO J 7: 2025-2033, 1988.
5. Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A: B-FGF as an autocrine growth factor for human melanomas. Oncogene Res 3: 177-186, 1988.
6. Golde DW, Bersch N, Li CH: Growth hormone: species specific stimulation of erythropoiesis in vitro. Science 196: 112-113, 1976.
7. Golde DW, Bersch N, Li CH: Growth hormone modulation of murine erythroleukemia cell growth in vitro. Proc Natl Acad Sci USA 75: 3437-3439, 1978.
8. Mercola KE, Cline MJ, Golds DW: Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood 58: 337-340, 1981.
9. Prieto JC, Carmena MJ: Growth hormone binding and stimulation of amino acid uptake in epithelial cells of rat ventral prostrate. Cell Biochem Funct 5: 63-68, 1987.
10. Cook JJ, Hatnes KM, Werther GA: Mitogenic effects of growth hormone in cultured human fibroblasts. J Clin Invest 81: 206-212, 1988.
11. Nielsen JH, Linde S, Welinder BS, Billestrup N, Madsen OD: Growth hormone is a growth factor for the differentiated pancreatic b-cell. Mol Endo 3: 165-173, 1989.
12. Maor G, Hochberg Z, Von der Mark K, Heinegard D, Silbermann M: Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125: 1239-1245, 1989.
13. Daughaday WH, Hall K, Raben MS: Somatomedin: proposed designation for sulphation factor. Nature 235: 107-109, 1972.
14. Hynes MA, Van Wyk JJ, Brooks PJ, D'Ercole AJ, Lund PK: Growth hormone dependence of somatomedin C-insulin like growth factor I and insulin like growth factor II messenger ribonucleic acids. Mol Endo 1: 233-242, 1987.
15. Ezzat S and Melmed S: Clinical review 18. Are patients with acromegaly at increased risk for neoplasia ? J Clin Endocrinol Metab 72: 245-249, 1991.
16. Bourgignon JP, Pierard E, Ernould C, Heinrichs C, Craen M, Rochiccioli P, Arrese JE, Franchimont C:Effect of human growth hormone therapy on melanocytic naevi. Lancet 341: 1505-1506, 1993.
17. Argetsinger LS, Campbell GS, Yang X: Identification of JAK2 as a growth hormone receptor associated kinase. Cell 74: 1-20, 1993.
18. Baumgartner JW, Wells CA, Chen CM, Waters MJ: The role of the WSXWS equivalent motif. J Biological Chem 269: 29094-29101, 1994.
19. Beato, M: Gene regulation by steroid hormones. Cell 56: 335-344, 1989.
20. Buckley AR, Montgomery DW, HelldTix MJ, Zukoski CF, Putnam CW: Identification of prolactin receptors in hepatic nuciei. Arch Biochem Biophys 290: 198-206, 1992.
21. Lesniak MA, Roth J: Regulation of receptor concentration by homologous hormones: Effect on human GH on its receptor in IM-9 lymphocytes. J Biol Chem 251: 3720-3729, 1976.
22. Murphy LI, Lazarus L: The mouse fibroblast growth hormone receptor ligand processing and receptor modulation and turnover. Endocrinol 115: 1625-1632, 1984.
23. Kover K, Hung CH, Moore WV: The characteristics of hGH binding to liver macrophages. Horm Metab Res 18: 26-30, 1986.
24. Lincoln DT, El-Hifnawi E, Sinowatz F, Waters MJ: Immunohistochemical localization of growth hormone receptor binding protein in the mammalian cerebellum. Annals of Anatomy 176: 419-427, 1994.
25. Lincoln DT, Waters MJ, Breipohl W, Sinowatz F, Lobie P: Growth hormone receptor expression in proliferating rat mammary gland. Acta Histochem Suppl 40: 47-49, 1990.
26. Lincoln DT, Sinowatz F, El-Hifnawi E, Hughes RL, Waters: Evidence of a direct role for growth hormone in mammary gland proliferation and lactation. Anat Histol Embryol 24: 107-115, 1995.
27. Lincoln DT, Temmim L, Al-Jarallah MA, Mathew TC, Dashti H: Primary Ki-l lymphoma of the skin: expression of growth hormone receptors. Nutrition Suppl 11: 627-631, 1995.
28. Lincoln DT, Breipohl W, Wegener A: Immuno-histochemical demonstration of growth hormone receptors in stromal cells from long-term human bone marrow cultures (LTBMC). The Histochemical J 24: 626-627, 1992.
29. Lincoln DT, Sinowatz F, Gabius HJ, Gabius S, Temmim-Baker L, Baker H, Mathew CT: Subpopulations of stromal cells from long-term human bone marrow cultures: ontogeny of progenitor cells and expression of growth hormone receptors. Anat Hist Embryol 26: 11-28, 1997.
30. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ: Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Developmental Brain Res 74: 225-233, 1993.
31. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI: Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330: 537-543, 1987.
32. Werther GA, Haynes KM, Barnard R, Waters MJ: Visual demonstration of GH receptors on human growth plate chondrocytes. J Endo Metab 70: 1725-1731, 1990.
33. Barnard R, Bundesen PG, Rylatt DB, Waters MJ: Monoclonal antibodies to the rabbit liver growth hormone receptor, production and characterization. Endocrinology 115: 1805-1813, 1984.
34. Mertani HC, Morel G: In situ gene expression of growth hormone (GH) receptor and GH binding protein in adult male rat tissues. Mol Cell Endocrinol 109: 47-61, 1995.
35. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker HI, Kolle S, Waters MJ: Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 109: 141-159, 1998.
36. Sporn MB, Roberts AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
37. Goustin A.S, Leof E., Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46: 1015-1029, 1986.
38. Valverius EM, Vela T, Shankar V, Ciardiello F, Kim N, Salomon DS: Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce estrogen-independent phenotype. Int. J. Cancer 46: 712-718, 1990.
39. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD: Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res 46: 285-292, 1986.
40. Berger MS, Greenfield C, Gullick WJ, Haley J, Downard J, Neal DE, Harris AL, Waterfield MD: Evaluation of epidermal growth factor receptors in bladder tumours. Brit. J, Cancer 56: 533-537, 1987.
41. Lu SH, Hsieh LL, Luo F, Weinstein IB: Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 42: 502-505, 1988.
42. Ishitoya J, Toriyama M, Oguchi N, Ohshima M, Asano K, Yamamoto T: Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Brit J Cancer 59: 559-562, 1989.
43. Wong AJ, Bigner SH, Bigner DD, Kinzler K, Hamilton S, Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci (Wash.) 84: 6899-6903, 1987.
44. Koprowski H, Herlyn M, Balaban G: Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosomal 7 in malignant melanoma. Somat Cell Mol Genen 11: 297-302, 1985.
45. Paul E, Gerhardt H: Morphologic investigations on the dynamics of nevus development. Virchows Arch Cell Pathol 43: 337-348, 1983.
46. Takahashi H, Strutton GM, Parsons PG: Determination of proliferating fractions in malignant melanoma by a PCA/cylin monoclinal. Histopathology 18: 221-227, 1991.
47. Isaksson OG, Lindahl A, Nilsson A, Isgaard J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Rev 8: 426-438, 1987.
48. Lincoln DT, Breipohl W, Waters MJ, Parsons P, Lobie PE, El-Hifnawi E, Sinowatz F: Expression of growth hormone receptors in human melanoma cells. Anat. Anzeiger 172: 51, 1991.
49. Artega CL, Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49: 6237-6241, 1989.
50. Minuto F, Del Monte P, Barreca A, Fortini P, Cariola G, Catrambone G, Giordano G: Evidence for an increased somatomedin c/insulin-like growth factor I content in primary human lung tumours. Cancer Res 46: 985-988, 1986.
51. De Larco JE, Todaro GJ: A human fibrosarcoma cell line producing multiplication stimulating activity (MSA) related peptides. Nature 272: 356-358, 978.
52. Blatt J, White C, Dienes S, Friedman H, Foley TP: Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Commun 123: 373-376, 1984.
53. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB: Secretion of an insulin-like growth factor I related protein by human breast cancer cells. Cancer Res 46: 4613-4619, 1986.
54. Stracke, ML, Kohn EC, Amaroorian SA, Wilson LL, Soloman D, Krutzch HC, Liotta LA, Schiffman E: Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun 153: 1076-1081, 1988.
55. Quafe CJ, Mathews LS, Pinkert CA: Hammer RE, Brinster RL, Palmiter RD: Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinol 124: 40-48, 1989.
56. Doglio AJ, Dani C, Fredrikson G: Acute regulation of IGF-I gene expression by growth hormone during adipose cell differentiation. EMBO J 6: 4011-4016, 1987.
57. Lowe WL, Roberts CT, Lasky SR: Differential expression of alternative 5' untranslated regions in RNAs encoding rat insulin-like growth factor I. Proc Natl Acad Sci USA 84: 8946-8950, 1987.
58. Daughaday WH, Trivedy B: Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA 84: 4636-4640, 1987.
59. Rabonovitch A, Quigley C, Rechler MM: Growth hormone stimulates islet ß-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 32: 307-312, 1983.
60. Andrew GS: Growth hormone and malignancy. J Clin Pathol 36: 935-937, 1983.
61. Murphy LJ, Bell GI, Friesen HG: Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo. Endocrinol 120: 1806-1812, 1987.
62. Ward HC, Halliday D, Sim AJW: Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 206: 56-61, 1987.
63. Gosney MA, Gosney JR, Lye M: Plasma growth hormone and digital clubbing in carcinoma of the bronchus. Thorax 45: 545-547, 1990.
64. Brunner JE, Johnson CC, Zafer S: Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 132: 65-71, 1990.
65. Ziel FH, Peters AL: Acromegaly and gastrointestinal adenocarcinomas. Ann Intern Med 109: 514-515, 1988.
66. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF: Acromegaly and gastrointestinal cancer. Cancer 68: 1673-1677, 1991.
67. Ratner RE, Hare JW: Association of acromegaly and chondro-sarcoma. South Med J 76: 1181-1182, 1983.
68. Haegg E and Asplun K: Acromegaly and multiple myeloma. Ann Intern Med 108: 437-438, 1988.
69. Stahnke N: Leukemia in growth hormone treated patients: An update. Hormone Res 38 (Suppl 1): 56-62, 1992.
70. Barzilay J, Heatley J, Cushing GW: Benign and malignant tumours in patients with acromegaly. Arch Intern Med 151: 1629-1633, 1991.
71. Conte PF, Gardin G: In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results. J Steroid Biochem Mol Biol 37: 1103-1108, 1990.
72. Husman B, Haldosen LA, Andersson G, Gustafsson JA: Characterization of the somatogenic receptor in rat liver. Hydrodynamic properties and affinity cross linking. J Biol Chem, 263: 3963-3970, 1988.
73. Lincoln DT, El-Hifnawi E: Growth hormone receptor expression in human keratinocytes. Cell Biol Intern 18: 484, 1984.
74. Herington AC, Ymer SI, Tiong TS: Does the serum binding protein for growth hormone have a functional role ? Acta Endocrinol 124: 14-20, 1991.
75. Levinovitz A, Husman B, Eriksson L, Norstedt G, Andersson G: Decreased expression of the growth hormone receptor and growth hormone binding protein in rat liver nodules. Mol Carcinog 3: 157-164, 1990.
76. Waters MJ, Barnard R, Lobie PE, Lim L, Hamlin G, Spencer SA, Hammonds RG, Leung DW, Wood WI: Growth hormone receptors-their structure, location and role. Acta Paed Scand Suppl 536: 60-72, 1990.
77. Baumann G, Amburn KD, Buchanan TA: The effect of circulating growth hormone- binding protein on metabolic clearance, distribution and degradation of human growth hormone. J Clin Endocrinol Metab 64: 657-660, 1987.
78. Edens A, Southard JN, Talamantes F: Mouse growth hormone-binding protein and growth hormone receptor transcripts are produced from a single gene by alternative splicing. Endocrinology 135: 2802-2805, 1994.
79. Lobie PE, Wood TJ, Sliva D, Billestrup N, Waters MJ, Enberg B, Norstedt G: The cellular mechanism of growth hormone signal transduction. Acta Paediatr Suppl 406; 39-46, 1994.
80. Rakowicz-Szulezynska EM, Meenhard H, Koprowski H: Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes and colorectal carcinoma cells in vitro. Cancer Res 48: 7200-7206, 1988.
81. Lobie PE, Barnard R, Waters MJ: The nuclear growth hormone receptor/binding protein. Antigenic and physiochemical characterization. J Biol Chem 266: 22645-22652, 1991.
82. Baumbach WA, Homer DL, Logan JS: The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 3: 1199-120, 1989.